John Mulder

John Mulder, CEO of Diagnoptics, advances the use of non-invasive AGE measurement in clinical practice. He is dedicated to supporting healthcare professionals with innovative diagnostic tools that enhance risk assessment, improve patient outcomes, and contribute to evidence-based management of diabetes and cardiovascular disease.